CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2023
Cash Flows from Operating Activities:
Net loss	$ (18,217)	$ (32,021)	$ (69,425)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	17,672	16,704	15,319
Amortization of operating lease right-of-use assets	5,039	4,781	4,639
Accounts receivable allowances	1,973	3,711	922
Stock-based compensation	88,086	59,895	67,769
Lease modification and impairment	0	0	1,601
Change in fair value of contingent consideration	(1,027)	(3,290)	(1,762)
Deferred income taxes	448	(22)	(912)
Other	389	239	154
Changes in operating assets and liabilities:
Accounts receivable	1,170	(5,138)	(26,402)
Unbilled receivables, current	(6,162)	(2,639)	(3,898)
Prepaid expenses and other assets	(8,003)	(5,740)	1,261
Deferred commissions	(3,716)	(4,066)	(3,394)
Accounts payable and accrued liabilities	13,491	9,438	2,313
Deferred revenue, net	35,327	28,261	46,565
Operating lease liabilities	(5,132)	(4,266)	(5,922)
Other liabilities	2,191	1,384	(1,341)
Net cash provided by operating activities	123,529	67,231	27,487
Cash Flows from Investing Activities:
Purchases of property and equipment	(1,673)	(2,457)	(2,212)
Capitalized internal-use software costs	(7,370)	(6,398)	(5,524)
Business combinations, net of cash acquired	(51,832)	(10,973)	(6,604)
Purchase of strategic investments	(2,000)	0	0
Net cash used in investing activities	(62,875)	(19,828)	(14,340)
Cash Flows from Financing Activities:
Proceeds from public offering, net of underwriting discounts	0	0	70,080
Payments for deferred offering costs	0	(781)	(790)
Proceeds from stock option exercises	40,845	30,726	23,456
Proceeds from employee stock purchase plan	4,080	3,431	2,700
Payments related to tax withholding for vested equity awards	0	0	(9,056)
Payments of contingent consideration and holdback associated with acquisitions	(3,742)	(3,051)	(22,290)
Net cash provided by financing activities	41,183	30,325	64,100
Effect of foreign currency exchange rate changes on cash and cash equivalents	2,902	(343)	(373)
Net increase in cash, cash equivalents and restricted cash	104,739	77,385	76,874
Cash, cash equivalents and restricted cash - beginning of period	208,570	131,185	54,311
Cash, cash equivalents and restricted cash - end of period	313,309	208,570	131,185
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:
Cash and cash equivalents	313,109	208,370	130,377
Restricted cash	200	200	808
Total cash, cash equivalents and restricted cash	313,309	208,570	131,185
Supplemental Disclosures of Cash Flow Information:
Cash paid for income taxes, net of tax refunds	3,024	2,184	1,812
Non-cash investing and financing activities:
Purchases of property and equipment in accounts payable and accrued liabilities	583	69	517
Capitalized internal-use software costs in accounts payable and accrued liabilities	938	702	378
Deferred offering costs in accounts payable and accrued liabilities	0	0	776
Contingent consideration and acquisition holdbacks in accounts payable, accrued expenses and other liabilities	1,134	3,052	5,941
Issuance of common stock in connection with a business combination	384	0	1,035
Stock-based compensation expense capitalized in internal-use software costs, net	478	0	0
Business combinations, net of cash acquired:
Cash paid	51,920	13,967	6,711
Cash acquired	(88)	(2,994)	(107)
Total consideration	$ 51,832	$ 10,973	$ 6,604